Phenotypic Alterations of Dendritic Cells Are Involved in Suppressive Activity of Trichosanthin-Induced CD8+CD28- Regulatory T Cells

被引:11
|
作者
Wang, Baolong [1 ]
Jiao, Zhijun [1 ,2 ]
Shao, Xiaoyi [1 ]
Lu, Liming [1 ]
Yang, Neng [1 ]
Zhou, Xiaorong [1 ]
Xin, Lijun [1 ]
Zhou, Yun [1 ]
Chou, Kuang-Yen [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China
[2] Jiangsu Univ, Affiliated Hosp, Dept Lab Med, Zhenjiang, Peoples R China
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 01期
关键词
IMMUNE-RESPONSES; GENETIC-CONTROL; CD8; CELLS; TYPE-1; COMPLEX; ACTIVATION; PROPERTY; PROTEIN; GLQ223;
D O I
10.4049/jimmunol.0901488
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The nature and differentiation of regulatory CD8(+)CD28(-) T cells are poorly understood. In this study, we demonstrate that native Ag trichosanthin (Tk), a highly purified linear peptide isolated from a Chinese medicinal herb, is able to induce strong suppression of OVA-specific lymphoproliferation at low concentrations via activation of IL-4/IL-10-secreting CD8(+)CD28(-) regulatory T cells (Tregs). To elucidate the underlying mechanisms, we firstly identified two types of mouse inbred strains, high susceptible (HS) and low susceptible, for the Tk-related suppression. They are H-2(d) (or H-2(b)) and H-2(k), respectively. The suppression is evoked only if bone marrow-derived dendritic cells (BDCs) instead of purified T cells are treated with Tk in an OVA-specific T-BDC interaction. Moreover, a special pattern of cytokine/transcription factors (IL-4(+)IL-10(+)IFN-gamma(-)Gata(3+)T-bet(-)) during suppressed OVA-specific T cell proliferation was observed in HS C57BL/6 but not in low-susceptible C3H/He mice. Consistently, the percentage of CD8(+)CD28(-) Tregs preferentially expanded from 5.5 to 26.1% in the presence of Tk, an occurrence that was also detected only in HS C57BL/6 mice. These expanded Tregs were able to induce a strong inhibition of one-way MLCs, which indicated that the Tk-induced hyporeaction and the activation of CD8(+)CD28(-) Tregs might be under the influence of different genetic backgrounds. Additionally, obvious alterations of phenotypic parameters of BDCs after Tk stimulation were also identified, including enhanced production of IL-10, decreased secretion of IL-12, and detection of Jagged1, a Notch ligand on BDCs. Collectively, our data suggest that the changed APC-related factors are essential, at least in part, for the activation and differentiation of Tk-induced CD8(+)CD28(-) Tregs. The Journal of Immunology, 2010, 185: 79-88.
引用
收藏
页码:79 / 88
页数:10
相关论文
共 50 条
  • [1] CD8+CD28-, suppressive T cells in systemic lupus erythematosus
    Tulunay, A.
    Yavuz, S.
    Direskeneli, H.
    Eksioglu-Demiralp, E.
    [J]. LUPUS, 2008, 17 (07) : 630 - 637
  • [2] CD8+CD28-, suppressive, T cells in systemic lupus erythematosus
    Tulunay, A
    Yavuz, S
    Ozilhan, G
    Elbir, Y
    Akdeniz, T
    Direskeneli, H
    Demiralp, EE
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 65 - 65
  • [3] Cd8+Cd28-, suppressive, T cells in systemic lupus erythematosus
    Tolunay, A
    Yavuz, S
    Ozilhan, G
    Elbir, Y
    Direskeneli, H
    Eksioglu-Demiralp, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 434 - 434
  • [4] Regulatory functions of CD8+CD28- T cells in an autoimmune disease model
    Najafian, N
    Chitnis, T
    Salama, AD
    Zhu, B
    Benou, C
    Yuan, XL
    Clarkson, MR
    Sayegh, MH
    Khoury, SJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 1037 - 1048
  • [5] CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells
    Xiaoyong Chen
    Qiuli Liu
    Andy Peng Xiang
    [J]. Cellular & Molecular Immunology, 2018, 15 : 734 - 736
  • [6] Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells
    Neuber, Brigitte
    Dai, Jingying
    Waraich, Wjahat A.
    Awwad, Mohamed H. S.
    Engelhardt, Melanie
    Schmitt, Michael
    Medenhoff, Sergej
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hundemer, Michael
    [J]. ONCOTARGET, 2017, 8 (58) : 98200 - 98214
  • [7] Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease
    Ceeraz, Sabrina
    Thompson, Charlotte R.
    Beatson, Richard
    Choy, Ernest H.
    [J]. CELLS, 2021, 10 (11)
  • [8] Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
    Houston, Timothy W.
    Howlett-Prieto, Quentin
    Regenauer, Colin
    Testai, Fernando D.
    Yao, Faith
    Feng, Xuan
    Reder, Anthony T.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (02):
  • [9] Mesenchymal stem cells control alloreactive CD8+CD28- T cells
    Engela, A. U.
    Baan, C. C.
    Litjens, N. H. R.
    Franquesa, M.
    Betjes, M. G. H.
    Weimar, W.
    Hoogduijn, M. J.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 (03): : 449 - 458
  • [10] Antigen-specific recognition is critical for the function of regulatory CD8+CD28- T cells
    Renner, P.
    Popp, F. C.
    Eggenhofer, E.
    Slowik, P.
    Piso, P.
    Geissler, E. K.
    Schlitt, H. J.
    Dahlke, M. H.
    [J]. TRANSPLANT IMMUNOLOGY, 2010, 22 (3-4) : 144 - 149